Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo
about
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathwayImaging Biomarkers in ImmunotherapySeeing stem cells at work in vivo.Switching on the lights for gene therapyIL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice.The basic principles of chimeric antigen receptor design.Noninvasive real-time imaging of apoptosis.Longitudinal, noninvasive imaging of T-cell effector function and proliferation in living subjects.Molecular imaging of cell-based cancer immunotherapy.Molecular imaging of gene expression and protein function in vivo with PET and SPECT.Molecular-genetic imaging: current and future perspectives.Targeting tumours with genetically enhanced T lymphocytes.Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo.Gene therapy progress and prospects: noninvasive imaging of gene therapy in living subjects.Role of reporter gene imaging in molecular and cellular biology.Imaging virus-associated cancer.In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease.Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brainNon-invasive imaging of adaptive immunity using positron emission tomography.Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigen.Noninvasive imaging of cell-mediated therapy for treatment of cancer.Multimodality imaging of TGFbeta signaling in breast cancer metastases.Shine a light: imaging the immune system.Nuclear imaging of cancer cell therapiesComparative Analysis of Human Nucleoside Kinase-Based Reporter Systems for PET Imaging.Noninvasive cell-tracking methods.Reporter gene imaging of immune responses to cancer: progress and challenges.Tracking and treating activated T cells.Molecular imaging in tracking tumor-specific cytotoxic T lymphocytes (CTLs).Advances in PET Detection of the Antitumor T Cell Response.Advancing Immune and Cell-Based Therapies Through Imaging.A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs.PET imaging of HSV1-tk mutants with acquired specificity toward pyrimidine- and acycloguanosine-based radiotracers.Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive molecular-genetic imaging.MRI of mouse models for gliomas shows similarities to humans and can be used to identify mice for preclinical trials.An improved strategy for the synthesis of [¹⁸F]-labeled arabinofuranosyl nucleosides.A method for quantification of nucleotides and nucleotide analogues in thymidine kinase assays using lanthanum phosphate coprecipitation.
P2860
Q24536061-0D0E2C3C-8FDE-4C9D-A2D0-B564F3F2BD14Q28079871-741CE83D-ABD5-4FE3-AA53-C9A28B913F09Q30420004-9353EEE3-0F30-4C9A-B860-0EAE25834745Q33287475-D8BA658F-A1B2-4403-A55D-D3B7F8E62E85Q33839836-6FE9CF56-5C65-408E-AAD7-54A0843B4E9AQ34036213-F8ED3753-FAFA-407E-9391-66D305BB07CBQ34429029-D0D36513-4873-4B05-83FE-6DFC07D1FF88Q34676977-EA1C25A4-14C9-4D71-83D3-9D0F2E51B1F4Q34717870-625CE941-CFA2-4C8A-8C73-27037DC29DA0Q34918519-E64D81EC-CB09-462B-97FE-63A707C6A291Q35019503-E6AFEDEF-4110-4506-B147-5B993925AD72Q35037678-A05D29F0-10CD-42B5-92D5-A7B0DBF82E83Q35215430-554470DA-CD92-4A84-AFE4-CA4C413982DEQ35623922-25D7406B-032E-46E1-A54C-CE35B09FE97DQ35804335-F42249F9-5428-48B1-BE51-F767535AF2A3Q36015054-9CDF1764-17A4-40EF-8B9F-E7DB36788760Q36488762-3C89F315-1E5C-44BA-8CF0-F045B480B97FQ37037932-B4FAFAF4-3FEC-4363-8EDE-9A85E7C62814Q37084904-1799F358-E655-4788-8F19-8567389BA4DDQ37090163-E944A8A8-06B2-476E-B12F-BA486E0A2407Q37181560-B1982F77-6AA8-4FB8-B62D-30B60DB4A09AQ37280775-804A0BD9-E763-4ABA-9BDF-3C61A3FB97AEQ37465020-EAA3FFCB-615A-4A52-A3B9-E11862D46EF2Q37518962-6016223D-7562-49F7-821D-D0DA26B41AD5Q37693526-B9D6524E-B0CC-443C-AEC6-CDF335217AE3Q37938642-14F230B0-A23A-42E4-985E-262CA272A6A1Q38003152-E9D7FF09-2917-4ED5-A616-B3D8B7976134Q38198637-111159C3-FA45-4BCB-84CF-15CCB4907150Q38243329-E3D209B4-5895-4A53-8297-B36ACEAD9035Q38846891-3BA90E3F-EF4F-4A51-B813-E52E9D6EEF69Q39167485-B4E1A4F6-CA85-483D-AC27-72700047AEC5Q39660810-C1BCA40D-9119-41B3-B186-3DC9F8A529BAQ39877451-70E896D2-8D2C-43A7-B9D9-3CF5E9D250F6Q41589159-CF3CA698-7427-4260-8204-0F2E36FC9B34Q41687215-5EAE39FE-0938-41A0-9126-2B11F1D9A7ABQ42399945-84B8F3C1-26EF-4981-A733-348B489B0201Q42585589-6602F9FC-9B80-4AC4-ABBD-99C327CEDC96
P2860
Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Imaging TCR-dependent NFAT-med ...... on emission tomography in vivo
@ast
Imaging TCR-dependent NFAT-med ...... on emission tomography in vivo
@en
Imaging TCR-dependent NFAT-med ...... on emission tomography in vivo
@nl
type
label
Imaging TCR-dependent NFAT-med ...... on emission tomography in vivo
@ast
Imaging TCR-dependent NFAT-med ...... on emission tomography in vivo
@en
Imaging TCR-dependent NFAT-med ...... on emission tomography in vivo
@nl
prefLabel
Imaging TCR-dependent NFAT-med ...... on emission tomography in vivo
@ast
Imaging TCR-dependent NFAT-med ...... on emission tomography in vivo
@en
Imaging TCR-dependent NFAT-med ...... on emission tomography in vivo
@nl
P2093
P2860
P1433
P1476
Imaging TCR-dependent NFAT-med ...... on emission tomography in vivo
@en
P2093
J Balatoni
J G Tjuvajev
M Doubrovin
M Sadelain
R Blasberg
T Beresten
P2860
P304
P356
10.1038/SJ.NEO.7900204
10.1038/SJ/NEO/7900204
P407
P577
2001-11-01T00:00:00Z